Bruhn Suzanne Louise
SEC CIK 1517790 · EDGAR
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 16:30 | 2026-06-11 | DFTX | Definium Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +4,666 | 24.3K | +24% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Travere Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +4,000 | 32.8K | +14% | $0 |
| D | 2025-05-16 | 2025-05-15 | TVTX | Travere Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +6,500 | 28.8K | +29% | $0 |
| D | 2024-05-10 | 2024-05-08 | TVTX | Travere Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +6,500 | 22.2K | +41% | $0 |
| D | 2023-06-23 | 2023-06-21 | DFTX | Definium Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +13.7K | 19.6K | +230% | $0 |
| D | 2023-05-19 | 2023-05-17 | TVTX | Travere Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +4,500 | 15.8K | +40% | $0 |
| D | 2022-08-15 | 2022-08-11 | DFTX | Definium Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +89.3K | 89.3K | New | $0 |
| D | 2022-05-12 | 2022-05-11 | TVTX | Travere Therapeutics, Inc. | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +3,000 | 11.2K | +36% | $0 |
Purchase Sale Sale after option exercise All abbreviations